InspireMD Inc (NSPR) - Product Pipeline Analysis, 2019 Update

Published by Global Data on 12th November 2019 | Ref: 1463941 | This Product Is In Stock

$750 | Single User
$1500 | Site License
$2250 | Global License
$750 | Single User
$1500 | Site License
$2250 | Global License

Introduction

Summary

InspireMD Inc (InspireMD) is a medical device company that develops and commercializes embolic prevention systems and neurovascular devices. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, acute myocardial infarction, and saphenous vein graft coronary intervention. It utilizes MicroNet stent platform technology to develop its products and offers solutions for various disease conditions such as stenting, embolic showers, restenosis and late stent thrombosis. The company markets its products through a network of distributors in Israel and Germany. InspireMD is headquartered in Tel Aviv, Israel.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company InspireMD Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

InspireMD Inc Company Overview

InspireMD Inc Company Snapshot

InspireMD Inc Pipeline Products and Ongoing Clinical Trials Overview

InspireMD Inc – Pipeline Analysis Overview

InspireMD Inc - Key Facts

InspireMD Inc - Major Products and Services

InspireMD Inc Pipeline Products by Development Stage

InspireMD Inc Ongoing Clinical Trials by Trial Status

InspireMD Inc Pipeline Products Overview

CGuard Embolic Prevention System

CGuard Embolic Prevention System Product Overview

CGuard Embolic Prevention System Clinical Trial

MGuard Drug Eluting Stent

MGuard Drug Eluting Stent Product Overview

Next Gen CGuard - 5F

Next Gen CGuard - 5F Product Overview

NGuard

NGuard Product Overview

PVGuard

PVGuard Product Overview

RGuard Renal

RGuard Renal Product Overview

InspireMD Inc - Key Competitors

InspireMD Inc - Key Employees

InspireMD Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

InspireMD Inc, Recent Developments

Sep 09, 2019: InspireMD provides business update

Aug 06, 2019: InspireMD announces second quarter 2019 financial results

May 14, 2019: InspireMD reports first quarter 2019 financial results

Feb 19, 2019: InspireMD announces fourth quarter 2018 financial results

Jan 24, 2019: InspireMD announces presentation of interim data from investigator-initiated study comparing CGuard EPS with a conventional open-cell carotid stent

Jan 23, 2019: InspireMD Announces Two Successful Live Clinical Case Transmissions Featuring CGuard EPS at the Leipzig Interventional Course (LINC) 2019

Jan 22, 2019: InspireMD announces results from initial clinical study of the CGuard Embolic Prevention System (EPS) with SmartFit technology

Jan 18, 2019: InspireMD’s CGuard Embolic Prevention System to be prominently featured in live case transmissions at LINC

Jan 14, 2019: InspireMD Announces the Distribution of CGuard Embolic Prevention System in South Africa

Jan 11, 2019: InspireMD receives noncompliance notice from NYSE American

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer

Additional Details

Publisher

Global Data

Publisher Information

Reference

1463941 | GDME8187PD

Number of Pages

34

Report Format

PDF

Related Reports

This report is published by Global Data

Global Data deliver comprehensive, detailed market intelligence that provides a definitive picture of the markets they serve. Their data is complete, detailed, global and completely cross-country comparable.

With different types of data other providers don’t provide, our clients can access a variety of tools that add context to our core data including innovation tracking, sentiment analysis, price monitoring, M&A tracking, competitor intelligence, and city-level intelligence.

Download Free Report Summary PDF

InspireMD Inc (NSPR) - Product Pipeline Analysis, 2019 Update | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.